Unknown

Dataset Information

0

KDM5B histone demethylase controls epithelial-mesenchymal transition of cancer cells by regulating the expression of the microRNA-200 family.


ABSTRACT: Histone methylation is implicated in various biological and pathological processes including cancer development. In this study, we discovered that ectopic expression of KDM5B, a histone H3 lysine 4 (H3K4) demethylase, promoted epithelial-mesenchymal transition (EMT) of cancer cells. KDM5B increased the expression of transcription factors, ZEB1 and ZEB2, followed by downregulation of E-cadherin and upregulation of mesenchymal marker genes. The expression of the microRNA-200 (miR-200) family, which specifically targets ZEB1 and ZEB2, was reduced in the cells with KDM5B overexpression. We found that KDM5B repressed the expression of the miR-200 family by changing histone H3 methylation status of their regulatory regions. The introduction of miR-200 precursor in the cells inhibited EMT induction by KDM5B, suggesting that miR-200 family was a critical downstream mediator of KDM5B-promoted EMT. Furthermore, knockdown of KDM5B was shown to affect the expression of EMT-related genes, indicating the involvement of endogenous KDM5B. Our study demonstrated a novel role of KDM5B histone lysine demethylase in EMT, which may contribute to malignant progression of cancer.

PROVIDER: S-EPMC3737312 | BioStudies | 2013-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2011-01-01 | S-EPMC3092351 | BioStudies
1000-01-01 | S-EPMC4766458 | BioStudies
2009-01-01 | S-EPMC3400149 | BioStudies
2018-01-01 | S-EPMC5881466 | BioStudies
2008-01-01 | S-EPMC3258899 | BioStudies
2013-01-01 | S-EPMC3754282 | BioStudies
2014-01-01 | S-EPMC4036258 | BioStudies
2010-01-01 | S-EPMC2933868 | BioStudies
2016-01-01 | S-EPMC4758077 | BioStudies
2012-01-01 | S-EPMC3330264 | BioStudies